6/24/2019 9:08:28 AM
Loxo Oncology Enters Strategic Partnership Agreement With AmoyDx, PREMIA
6/19/2019 1:04:01 PM
Eli Lilly And Co. (LLY) Declares $ 0.645 Dividend for Q3 19, Record Date 8/15/2019
6/19/2019 12:07:13 PM
Eli Lilly And Co. Declares Quarterly Dividend Of $0.645/share, Payable Sept. 10/ Record Aug. 15
6/14/2019 6:48:44 AM
Lilly Presents Positive Results For Taltz Vs. Humira In SPIRIT-H2H Superiority Study At EULAR
6/11/2019 3:04:17 AM
Eli Lilly To Present Positive, Five-year Phase 3 Data For Taltz
6/6/2019 6:47:16 AM
Lilly To Present Data For Taltz And Olumiant At EULAR 2019
6/5/2019 6:47:23 AM
Lilly To Present Data For Taltz, Olumiant And Mirikizumab At 24th World Congress Of Dermatology
6/4/2019 9:06:44 PM
Lilly Says FDA Approves Emgality Injection For Treatment Of Episodic Cluster Headache In Adults
6/4/2019 7:31:24 AM
Lilly: FDA Accepts NDA For Triple Combination Tablet For Adults With Type 2 Diabetes
6/3/2019 9:08:38 AM
Atomwise Announces Multi-year Agreement With Eli Lilly
5/28/2019 7:59:19 AM
Lilly To Acquire Exclusive Worldwide Rights For CNTX-0290 From Centrexion Therapeutics
5/28/2019 7:56:28 AM
Eli Lilly Announces License Agreement To Acquire Exclusive Worldwide Rights For CNTX-0290 From Centrexion